GENETIC PREDISPOSITION TO DISEASE

Clinical trials for GENETIC PREDISPOSITION TO DISEASE explained in plain language.

Never miss a new study

Get alerted when new GENETIC PREDISPOSITION TO DISEASE trials appear

Sign up with your email to follow new studies for GENETIC PREDISPOSITION TO DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 1 Not yet finished but already full! 5 Completed 7

Could a common drug shield the brain from Alzheimer's?

Prevention Not yet recruiting

This phase 1 trial tests whether sirolimus (rapamycin), an FDA-approved medication, can improve blood flow and energy use in the brains of women aged 45 to 65 who carry the ApoE4 gene — a gene that raises the risk of developing Alzheimer's disease. Participants are randomly assig…

Matched conditions: GENETIC PREDISPOSITION TO DISEASE

Phase: PHASE1 • Sponsor: University of Missouri-Columbia • Aim: Prevention

Last updated Aug 01, 2026 00:00 UTC

GENETIC PREDISPOSITION TO DISEASE

Get alerted when new GENETIC PREDISPOSITION TO DISEASE trials appear

Could a common drug shield the brain from Alzheimer's?